Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Sleep Apnea

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...

Sleep-Wake Cycles

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:

Overview of Lipid Metabolism

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

Inborn Errors of Metabolism

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...

Acute Respiratory Failure-II

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Anthropometric indices with high sensitivity for moderate-to-severe obstructive sleep Apnea: A sex-stratified diagnostic accuracy study based on the ESADA cohort.

Sleep medicine·2026

Same author

Efficacy and effectiveness of melatonin for the management of musculoskeletal pain: a systematic review and meta-analysis of placebo and active controlled trials.

Pain·2026

Same author

The Agreement between Fatmax and the Gas-Exchange and Blood Lactate Thresholds: A Systematic Review and Meta-Analysis.

Medicine and science in sports and exercise·2026

Same author

The Sleep and Breathing Conference: a long-standing and unique ERS/ESRS educational activity.

European respiratory review : an official journal of the European Respiratory Society·2026

Same author

Patients' attitudes toward melatonin for musculoskeletal pain: Insights for rehabilitation practice.

Physiotherapy·2026

Same author

OSA Endotyping as Targets for Treatment. How Far Have We Come?

Respirology (Carlton, Vic.)·2026

Search research articles

Related Experiment Video

Updated: May 8, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

Sleep apnoea and metabolic dysfunction.

Maria R Bonsignore¹, Anne-Laure Borel, Elizabeth Machan

¹Section of Pneumology, University of Palermo, Palermo, France. marisa@ibim.cnr.it

European Respiratory Review : an Official Journal of the European Respiratory Society

|September 3, 2013

Summary

This summary is machine-generated.

Obstructive sleep apnoea (OSA) is linked to metabolic issues like type 2 diabetes. Lifestyle changes can improve both OSA and metabolic health.

More Related Videos

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

Related Experiment Videos

Last Updated: May 8, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Published on: October 18, 2024

Area of Science:

Sleep Medicine
Metabolic Disorders
Endocrinology

Background:

Obstructive sleep apnoea (OSA) is prevalent, particularly in individuals with central obesity.
Emerging research suggests OSA may independently contribute to metabolic abnormalities such as type 2 diabetes, metabolic syndrome, and non-alcoholic fatty liver disease.
Chronic intermittent hypoxia models in animal studies provide insights into pathophysiological mechanisms.

Purpose of the Study:

To review the current understanding of the relationship between obstructive sleep apnoea and metabolic dysfunction.
To summarize key findings on the role of OSA in obesity-related metabolic consequences.
To discuss the impact of lifestyle interventions on respiratory disturbances and metabolic profiles in OSA patients.

Main Methods:

This review synthesizes state-of-the-art lectures from a dedicated session.
It integrates findings from clinical literature and animal studies on chronic intermittent hypoxia.
Focuses on the interplay between sleep apnoea, obesity, and metabolic health.

Main Results:

OSA is associated with an increased risk of developing type 2 diabetes and metabolic syndrome.
Intermittent hypoxia in OSA contributes to insulin resistance and hepatic steatosis.
Lifestyle interventions, including diet and exercise, show promise in improving both OSA severity and metabolic parameters.

Conclusions:

Obstructive sleep apnoea is a significant factor in the pathogenesis of metabolic dysfunction.
Targeting OSA through lifestyle modifications may offer a dual benefit for respiratory and metabolic health.
Further research is warranted to elucidate the complex interactions between sleep, breathing, and metabolism.